Diligence memo · auto-generated · as of July 1, 2026
Zipari, Inc.
Zipari, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Zipari, Inc. operates in Other Health Care, based in Brooklyn.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Zipari, Inc. has raised $30M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $15M on 2019-06-14.
Most recent recorded round closed around 2020-05-12.
Valuation (modeled)modeled
Provath models Zipari, Inc. at approximately $208M (range $13M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.06× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 20 months.
Last raise 6.1 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.5× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 88% of Other Health Care peers (5376 compared).
Modeled value ranks above 88% of those peers.
Closest niche peers: iVinci Partners, LLC, InvestCo Tabletop, LLC, Mediphore, Inc., Oklahoma Proton Center LLC, MicroOptx, Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.